Lidanserin

Lidanserin
Clinical data
Other names	ZK-33,839; ZK-33839; ZK33839
Drug class	Serotonin 5-HT2A receptor antagonist; α1-Adrenergic receptor antagonist
ATC code	None;
Identifiers
	IUPAC name 4-(3-{3-[4-(4-fluorobenzoyl)-1-piperidinyl]propoxy}-4-methoxyphenyl)-2-pyrrolidinone;
CAS Number	73725-85-6;
PubChem CID	68919;
ChemSpider	62146;
UNII	80O1E9JZLN;
CompTox Dashboard (EPA)	DTXSID60868269 ;
Chemical and physical data
Formula	C26H31FN2O4
Molar mass	454.542 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Fc1ccc(cc1)C(=O)C4CCN(CCCOc2cc(ccc2OC)C3CC(=O)NC3)CC4;
	InChI InChI=1S/C26H31FN2O4/c1-32-23-8-5-20(21-16-25(30)28-17-21)15-24(23)33-14-2-11-29-12-9-19(10-13-29)26(31)18-3-6-22(27)7-4-18/h3-8,15,19,21H,2,9-14,16-17H2,1H3,(H,28,30); Key:JDYWZVJXSMADHP-UHFFFAOYSA-N;

Lidanserin (INNTooltip International Nonproprietary Name; ZK-33,839) is a drug which acts as a combined 5-HT_2A and α₁-adrenergic receptor antagonist.^[1] It was developed as an antihypertensive agent but was never marketed.^[1]

Other namesZK-33,839; ZK-33839; ZK33839

Quick facts Clinical data, Other names ...

Close

See also